Cybrexa Therapeutics to Present at BTIG Virtual Biotechnology Conference 2021
04 août 2021 11h50 HE
|
Cybrexa Therapeutics
NEW HAVEN, Conn., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ Peptide Drug...
HiberCell Initiates Phase 1a Clinical Trial of HC-5404-FU, an ER Stress Modulator
10 juin 2021 08h00 HE
|
HiberCell
NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company dedicated to overcoming foundational barriers that prevent patients from living longer, cancer-free lives, today...
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
08 juin 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
03 juin 2021 09h27 HE
|
COMPASS Pathfinder Ltd.
LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
HiberCell Closes $67.4 Million Series B Financing and Secures $30 Million Debt Facility from Hercules Capital
19 mai 2021 08h00 HE
|
HiberCell
Proceeds to advance pipeline of clinical product candidates focused on preventing cancer relapse and metastasis NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- HiberCell, a biotechnology company...
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021
13 mai 2021 07h00 HE
|
COMPASS Pathfinder Ltd.
Highlights: New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Two...
COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021
06 mai 2021 08h00 HE
|
COMPASS Pathfinder Ltd.
London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
FluroTech Announces Non-Brokered Private Placement of Units
07 déc. 2020 08h45 HE
|
FluroTech Ltd.
CALGARY, Alberta, Dec. 07, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce a non-brokered private placement of units...
ZRG Acquires Toft Group, a Leader in Life Sciences and Biotech Recruiting
14 nov. 2019 09h30 HE
|
ZRG Partners
ROCHELLE PARK, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- ZRG, the fastest growing global executive search firm, today announced that it has acquired the Toft Group, a market leader in the placement of...